A Non-Interventional, Open Label, Phase IV Observational Study for the Safety and Efficacy of Switching to Quetiapine (Seroquel) in Outpatients With Schizophrenia Who Have Been Unsuccessfully Treated With Other Antipsychotics

Trial Profile

A Non-Interventional, Open Label, Phase IV Observational Study for the Safety and Efficacy of Switching to Quetiapine (Seroquel) in Outpatients With Schizophrenia Who Have Been Unsuccessfully Treated With Other Antipsychotics

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2010

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Acronyms Q-chase
  • Sponsors AstraZeneca
  • Most Recent Events

    • 08 Dec 2010 Last checked against clinicaltrials.gov record.
    • 25 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top